Inloggen
Inloggen
Of aanmelden met
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Registreer
Of aanmelden met
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

GLOBAL BLOOD THERAPEUTICS, INC.

(GBT)
Vertraagde tijd Nasdaq  -  22:00 04-10-2022
68.49 USD   +0.01%
06/10BioPharma Credit ontvangt $175 miljoen van Global Blood Therapeutics investering
MT
05/10Global Blood Therapeutics, Inc. Kondigt aan dat Ted W. Love stopt als Chief Executive Officer
CI
05/10Global Blood Therapeutics, Inc. Kondigt wijzigingen in de leiding aan
CI
OverzichtKoersenGrafiekenNieuwsRatingsAgendaOndernemingFonds 
OverzichtAl het nieuwsAanbevelingen van analistenAndere talenPersberichtenOfficiŽle publicatiesSectornieuws
Communiquťs de presse de la sociťtť GLOBAL BLOOD THERAPEUTICS, INC.
27/10Pfizer Completes $5.4 Billion Acquisition Of Sickle Cell Disease Drug Innovator
AQ
05/10Global Blood Therapeutics, Inc. : Entry into a Material Definitive Agreement, Termination ..
AQ
30/09Global Blood Therapeutics, Inc. : Submission of Matters to a Vote of Security Holders, Oth..
AQ
23/09Global Blood Therapeutics, Inc. : Other Events (form 8-K)
AQ
16/09GBT Supports the Sickle Cell Disease Treatment Centers Act of 2022
AQ
08/09GBT and Sickle Cell Disease Association of America to Host 11th Annual Sickle Cell Dise..
AQ
31/08Global Blood Therapeutics Investor A : Kahn Swick & Foti, LLC Investigates Adequacy of Pri..
BU
10/08Pfizer spending spree filters to Biopharma
AQ
09/08Global Blood : Q2 Earnings Snapshot
AQ
09/08Pfizer scoops up Global Blood Therapeutics in $5.4bn deal
AQ
09/08Global Blood Therapeutics Investor A : Kahn Swick & Foti, LLC Investigates Adequacy of Pri..
BU
08/08Pfizer buying spree continues with $5.4B hematology deal
AQ
08/08Global Blood Therapeutics : Pfizer to Acquire Global Blood Therapeutics for $5.4 Billion t..
PU
08/08GLOBAL BLOOD THERAPEUTICS, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL COND..
AQ
08/08Global Blood Therapeutics, Inc. : Entry into a Material Definitive Agreement, Amendments t..
AQ
04/08GBT Announces New Employment Inducement Grants
AQ
03/08GBT Announces Participation at the Wedbush PacGrow Healthcare Conference
AQ
01/08GBT to Announce Second Quarter 2022 Financial Results on Monday, August 8, 2022
AQ
29/07GBT to Announce Second Quarter 2022 Financial Results on Monday, August 8, 2022
AQ
27/07Global Blood Therapeutics, Inc. - MHRA Grants Marketing Authorization for GBT's Oxbryta..
AQ
26/07Global Blood Therapeutics : MHRA Grants Marketing Authorization for GBT's Oxbrytaģ (voxelo..
PU
26/07Global Blood Therapeutics, Inc. : Other Events, Financial Statements and Exhibits (form 8-..
AQ
26/07MHRA Grants Marketing Authorization for GBT's Oxbrytaģ (voxelotor) for Use in Great Bri..
GL
26/07MHRA Grants Marketing Authorization for GBT's Oxbrytaģ (voxelotor) for Use in Great Bri..
AQ
14/07Global Blood Therapeutics : GBT Initiates Expanded Access Program for Voxelotor in Patient..
PU
14/07Global Blood Therapeutics, Inc. : Other Events, Financial Statements and Exhibits (form 8-..
AQ
14/07GBT Initiates Expanded Access Program for Voxelotor in Patients With Sickle Cell Diseas..
AQ
14/07Global Blood Therapeutics, Inc. - The GBT Foundation Awards $250,000 in ACE Grants to S..
AQ
13/07The GBT Foundation Awards $250,000 in ACE Grants to Support Sickle Cell Disease Communi..
AQ
07/07GBT Announces New Employment Inducement Grants
AQ
29/06Global Blood Therapeutics : Phase 2 portion designed to identify the optimal dose for the ..
PU
29/06Global Blood Therapeutics, Inc. : Other Events, Financial Statements and Exhibits (form 8-..
AQ
29/06GBT Initiates Phase 2/3 Clinical Trial of GBT601 in Patients with Sickle Cell Disease
AQ
27/06Global Blood Therapeutics : driving innovation in sickle cell disease
AQ
16/06NFL Running Back Tevin Coleman and Family Team Up with GBT to Share Playbook for Famili..
AQ
15/06Global Blood Therapeutics, Inc. : Submission of Matters to a Vote of Security Holders (for..
AQ
13/06Global Blood Therapeutics : Sickle Cell Health Awareness, Perspectives and Experiences (SH..
PU
13/06Global Blood Therapeutics, Inc. : Other Events, Financial Statements and Exhibits (form 8-..
AQ
13/06New GBT Multinational Survey Shines a Needed Light on the Misunderstood Realities, Unse..
GL
13/06New GBT Multinational Survey Shines a Needed Light on the Misunderstood Realities, Unse..
AQ
10/06Global Blood Therapeutics : GBT Presents Positive New Real-World Evidence Data at EHA2022 ..
PU
10/06Global Blood Therapeutics, Inc. : Other Events, Financial Statements and Exhibits (form 8-..
AQ
10/06GBT Presents Positive New Real-World Evidence Data at EHA2022 Congress Further Supporti..
GL
10/06GBT Presents Positive New Real-World Evidence Data at EHA2022 Congress Further Supporti..
AQ
07/06GBT's Inclacumab and GBT601 Receive U.S. FDA Orphan Drug and Rare Pediatric Disease Des..
AQ
06/06The GBT Foundation Opens 2022 ACCEL Grant Program to Provide Up to $500,000 in Support ..
AQ
06/06Global Blood Therapeutics : GBT's Inclacumab and GBT601 Receive U.S. FDA Orphan Drug and R..
PU
06/06Global Blood Therapeutics, Inc. : Other Events, Financial Statements and Exhibits (form 8-..
AQ
06/06GBT's Inclacumab and GBT601 Receive U.S. FDA Orphan Drug and Rare Pediatric Disease Des..
AQ
02/06GBT Announces New Employment Inducement Grants
AQ
01/06GBT to Host Investor Conference Call on Friday, June 10 and Participate in Upcoming Inv..
AQ
12/05Global Blood Therapeutics, Inc. : Other Events, Financial Statements and Exhibits (form 8-..
AQ
12/05GBT Announces Five Data Presentations on Sickle Cell Disease at Upcoming EHA2022 Congre..
AQ
05/05GBT Announces New Employment Inducement Grants
AQ
05/05GBT Announces Participation in Upcoming Investor Conferences
AQ
04/05GLOBAL BLOOD THERAPEUTICS, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL COND..
AQ
04/05Global Blood : Q1 Earnings Snapshot
AQ
04/05GBT Reports First Quarter 2022 Financial Results
AQ
28/04GBT Launches Inaugural Environmental, Social and Governance (ESG) Report
AQ
27/04GBT to Announce First Quarter 2022 Financial Results on Wednesday, May 4, 2022
AQ
07/04GBT Announces New Employment Inducement Grants
AQ
25/03Global Blood Therapeutics, Inc. : Change in Directors or Principal Officers (form 8-K)
AQ
24/03GBT Announces Participation at the Guggenheim Genomic Medicines & Rare Disease Day
AQ
10/03GBT Announces New Employment Inducement Grants
AQ
03/03The GBT Foundation Opens 2022 ACE Grant Program, Providing up to $250,000 in Support to..
AQ
28/02GBT Announces Participation in Upcoming Investor Conferences
AQ
23/02Global Blood : Q4 Earnings Snapshot
AQ
23/02Global Blood Therapeutics : GBT Reports Fourth Quarter and Full Year 2021 Financial Result..
PU
23/02GLOBAL BLOOD THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Cond..
AQ
23/02GBT Reports Fourth Quarter and Full Year 2021 Financial Results
AQ
17/02Global Blood Therapeutics, Inc. - European Commission Approves Oxbryta (voxelotor) for ..
AQ
16/02GBT to Announce Fourth Quarter and Full Year 2021 Financial Results on Wednesday, Febru..
AQ
16/02Global Blood Therapeutics : The first sickle hemoglobin polymerization inhibitor approved ..
PU
16/02Global Blood Therapeutics, Inc. : Other Events, Financial Statements and Exhibits (form 8-..
AQ
16/02European Commission Approves Oxbrytaģ (voxelotor) for the Treatment of Hemolytic Anemia..
GL
1  2  3  4  5  6Volgende
Volgende evenement op GLOBAL BLOOD THERAPEUTICS, INC.